Your browser doesn't support javascript.
loading
Epidemiology, diagnostics and factors associated with mortality during a cholera epidemic in Nigeria, October 2020-October 2021: a retrospective analysis of national surveillance data.
Elimian, Kelly; Yennan, Sebastian; Musah, Anwar; Cheshi, Iliya Danladi; King, Carina; Dunkwu, Lauryn; Mohammed, Ahmed Ladan; Ekeng, Eme; Akande, Oluwatosin Wuraola; Ayres, Stephanie; Gandi, Benjamin; Pembi, Emmanuel; Saleh, Fatima; Omar, Ahmed Nasir; Crawford, Emily; Olopha, Olubunmi Omowumi; Nnaji, Robinson; Muhammad, Basheer; Luka-Lawal, Rejoice; Ihueze, Adachioma Chinonso; Olatunji, David; Ojukwu, Chidimma; Akinpelu, Afolabi Muftau; Adaga, Ene; Abubakar, Yusuf; Nwadiuto, Ifeoma; Ngishe, Samuel; Alowooye, Agnes Bosede; Nwogwugwu, Peace Chinma; Kamaldeen, Khadeejah; Abah, Henry Nweke; Chukwuebuka, Egbuna Hyacinth; Yusuff, Hakeem Abiola; Mamadu, Ibrahim; Mohammed, Abbas Aliyu; Peter, Sarah; Abbah, Okpachi Christopher; Oladotun, Popoola Michael; Oifoh, Santino; Olugbile, Micheal; Agogo, Emmanuel; Ndodo, Nnaemeka; Babatunde, Olajumoke; Mba, Nwando; Oladejo, John; Ilori, Elsie; Alfvén, Tobias; Myles, Puja; Ochu, Chinwe Lucia; Ihekweazu, Chikwe.
Affiliation
  • Elimian K; Nigeria Centre for Disease Control, Abuja, Nigeria kelly.elimian@ki.se.
  • Yennan S; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.
  • Musah A; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Cheshi ID; Department of Risk and Disaster Reduction, University College London, London, UK.
  • King C; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Dunkwu L; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.
  • Mohammed AL; Tony Blair Institute for Global Change, London, UK.
  • Ekeng E; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Akande OW; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Ayres S; Department of Epidemiology and Community Health, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
  • Gandi B; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.
  • Pembi E; Bauchi State Ministry of Health, Bauchi, Nigeria.
  • Saleh F; Adamawa State Ministry of Health, Yola, Nigeria.
  • Omar AN; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Crawford E; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Olopha OO; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Nnaji R; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Muhammad B; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Luka-Lawal R; Kano State Ministry of Health, Kano, Nigeria.
  • Ihueze AC; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Olatunji D; Georgetown University, Abuja, Nigeria.
  • Ojukwu C; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Akinpelu AM; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Adaga E; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Abubakar Y; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Nwadiuto I; Zamfara State Ministry of Health, Zamfara State, Nigeria.
  • Ngishe S; Rivers State Ministry of Health, Port Harcourt, Nigeria.
  • Alowooye AB; Public Health, Ministry of Health, Benue State, Makurdi, Nigeria.
  • Nwogwugwu PC; Ekitit State Ministry of Health and Human Services, Ado-Ekiti, Nigeria.
  • Kamaldeen K; Abia State Ministry of Health, Umuanhia, Nigeria.
  • Abah HN; Kwara State Ministry of Health, Ilorin, Nigeria.
  • Chukwuebuka EH; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Yusuff HA; Imo State Ministry of Health, Owerri, Nigeria.
  • Mamadu I; Ogun State Ministry of Health, Abeokuta, Nigeria.
  • Mohammed AA; World Health Organization Country Office for Nigeria, Abuja, Nigeria.
  • Peter S; Ministry of Health, Sokoto State, Sokoto, Nigeria.
  • Abbah OC; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Oladotun PM; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Oifoh S; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Olugbile M; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Agogo E; World Bank Nigeria Office, Abuja, Nigeria.
  • Ndodo N; Resolve to Saves Lives, Abuja, Nigeria.
  • Babatunde O; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Mba N; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Oladejo J; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Ilori E; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Alfvén T; Nigeria Centre for Disease Control, Abuja, Nigeria.
  • Myles P; Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.
  • Ochu CL; Clinical Practice Research Datalink, London, UK.
  • Ihekweazu C; Nigeria Centre for Disease Control, Abuja, Nigeria.
BMJ Open ; 12(9): e063703, 2022 09 19.
Article in En | MEDLINE | ID: mdl-36123095
ABSTRACT

OBJECTIVES:

Nigeria reported an upsurge in cholera cases in October 2020, which then transitioned into a large, disseminated epidemic for most of 2021. This study aimed to describe the epidemiology, diagnostic performance of rapid diagnostic test (RDT) kits and the factors associated with mortality during the epidemic.

DESIGN:

A retrospective analysis of national surveillance data.

SETTING:

33 of 37 states (including the Federal Capital Territory) in Nigeria.

PARTICIPANTS:

Persons who met cholera case definition (a person of any age with acute watery diarrhoea, with or without vomiting) between October 2020 and October 2021 within the Nigeria Centre for Disease Control surveillance data. OUTCOME

MEASURES:

Attack rate (AR; per 100 000 persons), case fatality rate (CFR; %) and accuracy of RDT performance compared with culture using area under the receiver operating characteristic curve (AUROC). Additionally, individual factors associated with cholera deaths and hospitalisation were presented as adjusted OR with 95% CIs.

RESULTS:

Overall, 93 598 cholera cases and 3298 deaths (CFR 3.5%) were reported across 33 of 37 states in Nigeria within the study period. The proportions of cholera cases were higher in men aged 5-14 years and women aged 25-44 years. The overall AR was 46.5 per 100 000 persons. The North-West region recorded the highest AR with 102 per 100 000. Older age, male gender, residency in the North-Central region and severe dehydration significantly increased the odds of cholera deaths. The cholera RDT had excellent diagnostic accuracy (AUROC=0.91; 95% CI 0.87 to 0.96).

CONCLUSIONS:

Cholera remains a serious public health threat in Nigeria with a high mortality rate. Thus, we recommend making RDT kits more widely accessible for improved surveillance and prompt case management across the country.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholera / Epidemics Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Limits: Female / Humans / Male Country/Region as subject: Africa Language: En Journal: BMJ Open Year: 2022 Document type: Article Affiliation country: Nigeria

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholera / Epidemics Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Limits: Female / Humans / Male Country/Region as subject: Africa Language: En Journal: BMJ Open Year: 2022 Document type: Article Affiliation country: Nigeria